期刊文献+

人端粒酶逆转录酶基因启动子区的克隆及其真核表达载体的构建 被引量:4

Cloning of human telomerase reverse transcriptase gene promoter and construction of its eukaryotic expression vector
下载PDF
导出
摘要 目的 :构建人端粒酶逆转录酶基因启动子区的真核表达载体。方法 :用核酸内切酶NotⅠ和KpnⅠ酶切报告基因GFP ,插入pcDNA3.1 (+)载体 ,得到pcDNA3.1 (+) -GFP(PG)载体 ;用PCR方法扩增hTERT基因ATG上游的启动子序列 ,测序后用核酸内切酶BglⅡ和KpnⅠ酶切插入PG载体 ,得到pcDNA3.1 (+) -GFP -hTERT(PGT)载体。将PGT载体转染人食管癌EC970 6细胞系 ,经G4 1 8筛选 ,荧光显微镜下观察。结果 :克隆得到的启动子序列与文献相符 ,重组载体经酶切鉴定方向正确 ,含有人端粒酶逆转录酶基因启动子序列。经转染人食管癌EC970 6细胞系 ,在荧光显微镜下观察到绿色的阳性克隆。结论 :克隆的人端粒酶逆转录酶基因启动子序列在真核细胞中具有启动子活性。 Aim: To construct an eukaryotic expression vector containing human telomerase reverse transcriptase (hTERT) gene promoter and reporter green fluorescent protein(GFP). Methods: PCR amplification was performed using primers based on hTERT gene sequence from GenBank and human genomic DNA as a template. PCR product was directedly ligated into pMD18-T vector for sequencing. The promoter fragment was cloned into a pcDNA3.1(+)-GFP plasmid after it had been identified correctly. A human esophageal cancer cell line EC9706 was transfected with the plasmid containing hTERT promoter and reporter gene GFP, and the transfected cells were observed under fluorescent microscope 36 hours later. Results: A 733bp DNA fragment was amplified. Sequensing and restriction endonuclease digestion demonstrated that the fragment was cloned into the pcDNA3.1(+)-GFP-hTERT vector. Positive transfected cells with green fluorescence were detected under fluorescent microscope. Conclusion: The cloned hTERT promoter fragment in pcDNA3.1(+)-GFP-hTERT plasmid vector is active in human esophageal cancer cell line EC9706.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第1期44-47,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省重大科技攻关基金资助项目 0 12 2 0 3 2 5 0 0 河南省杰出人才创新基金资助项目 0 2 2 10 0 190 0
关键词 人端粒酶逆转录酶 启动子 真核表达载体 human telomerase reverse transcriptase (hTERT) promoter eukaryotic expression vector
  • 相关文献

参考文献9

  • 1姜泊 张亚历 等.分子生物学常用实验方法[M].北京:人民军医出版社,1998.88-94.
  • 2Meyerson M, Counter CM, Eaton EN, et al. hEST2,the putative human telomerase catalytic suhunit gene,is up-regula-ted in tumor cells and during immortalization. Cell, 1997,90(4) :785.
  • 3Cong YS, Wen J, Bacchetti S. The human telomerase catalytic suhunit hTERT:organization of the gene and characterization of the promoter. Hum Mol Genet,1999,8(1) :137.
  • 4Horikawa I, Cable PL, Afshari C, et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res, 1999,59(4) :826.
  • 5Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science, 1994,263(5 148) :802.
  • 6Kim NW, Piatyszek MA, Prowse KR, et al. Specific associatinn of human telomerase activity with immortal cells and cancer. Science,1994,266(5 193) :2011.
  • 7Morin GB. The implication of telomerase biochemistry for human disease. Eur J Cancer,1997,33(5):750.
  • 8Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett,2003,194(2) :209.
  • 9Gu J, Andreeff M, Roth JA, et al. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gene Ther, 2002, 9(1) :30.

共引文献11

同被引文献29

  • 1郭玉忠,姜国忠,李克虹,史惠蓉,王建民,薛乐勋.hTERT启动子调控的HSV-tk基因逆转录病毒载体的构建及SKOV3转染细胞的生物学特性观察[J].郑州大学学报(医学版),2004,39(4):566-569. 被引量:3
  • 2尹家俊,胡祥,傅攀峰,袁晓东,张锦瑜.端粒酶逆转录酶基因启动子调控的肿瘤细胞特异表达载体的构建和鉴定[J].中华医学杂志,2003,83(14):1274-1277. 被引量:3
  • 3黄慧敏,张红,李惠翔,姜国忠,高冬玲,王秀利.表达E2F1小干扰RNA的逆转录病毒载体的构建[J].实用诊断与治疗杂志,2005,19(3):177-179. 被引量:5
  • 4Jolly D. Viral vector systems for gene therapy. Cancer Gene Ther, 1994,1(1): 51
  • 5Marshall E. Improving gene therapy's tool kit. Science, 2000,288(5 468): 953
  • 6Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet, 2003, 4(5):346
  • 7Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res,2000,60(15) : 3 989
  • 8Xu L, Yee JK, Wolff JA, et al. Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology, 1989, 171(2): 331
  • 9Cao G, Kuriyama S, Gao J, et al. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP enhancer and a housekeeping gene promoter. Eur J Cancer, 2001, 37(1):140
  • 10Suzuki S, Tadakuma T, Kunitomi M, et al. Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells. Urol Int, 2001, 67(3):216

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部